T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)
Year: 2024
Type: article
Study design: Observational Study
Source: Expert Opinion on Drug Safety
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4405597691
